They identified significantly more frequent TP53 mutations (Q = 0.0044, Fisher’s exact test) in EBV-negative BL (but not sBL), which became more striking when considering all BL-associated genes with roles in apoptosis (Q = 0.00024) [11]. Here, TP53 is linked to Burkitt lymphoma.